Pfizer and German partner BioNTech announced the launch of their late-stage trial to test their COVID-19 vaccine in 30,000 people on Monday - hours after Moderna announced its own late-stage, large trial.
from Articles | Mail Online https://ift.tt/30WDxt6
No comments:
Post a Comment